Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

aldesleukin 22 Sunitinib 21 Bevacizumab 16 Interleukin-2 14 Everolimus 14 Interferon-alpha 13 Gemcitabine 13 Cyclophosphamide 13 fludarabine phosphate 11 Peripheral Blood Stem Cell Transplantation 9 Sorafenib 8 Filgrastim 8 Axitinib 8 Nivolumab 7 pembrolizumab 6 Ipilimumab 6 Doxorubicin 6 Carboplatin 6 sargramostim 5 cabozantinib 5 Capecitabine 5 Thalidomide 4 Tacrolimus 4 Radiotherapy 4 Radiosurgery 4 Neoadjuvant Therapy 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 Chemotherapy, Adjuvant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Kidney Neoplasms × Ketorolac Tromethamine × Clear all

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡